{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:04:58Z","timestamp":1770822298267,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T00:00:00Z","timestamp":1332892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s11748-011-0915-9","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T23:55:02Z","timestamp":1332806102000},"page":"289-296","source":"Crossref","is-referenced-by-count":22,"title":["Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy\u2019s and St Thomas\u2019 hospitals"],"prefix":"10.1007","volume":"60","author":[{"given":"Andrea","family":"Bille","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Belcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilgard","family":"Raubenheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Landau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Cane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efc","family":"Lang-Lazdunski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,28]]},"reference":[{"key":"915_CR1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thorax.55.9.731","volume":"55","author":"G. Edwards","year":"2000","unstructured":"Edwards G, Abrahams KR, Leverment JN, Spyt TJ, Waller DA, O\u2019Byrne KJ. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 2000;55:731\u2013735.","journal-title":"Thorax"},{"key":"915_CR2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(08)60727-8","volume":"371","author":"M.F. Muers","year":"2008","unstructured":"Muers MF, Stephens RJ, Fisher P, Darlison L, Higgs CM, Lowry E, et al. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial. Lancet 2008;371:1685\u20131694.","journal-title":"Lancet"},{"key":"915_CR3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.semtcvs.2009.07.007","volume":"21","author":"A.S. Wolf","year":"2009","unstructured":"Wolf AS, Daniel J, Sugarbaker DJ. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy\/decortication. Semin Thorac Cardiovasc Surg 2009;21:132\u2013148.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"915_CR4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jtcvs.2004.02.021","volume":"128","author":"D.J. Sugarbaker","year":"2004","unstructured":"Sugarbaker DJ, Jaklitsch MT, Bueno R, Richards W, Lukanich J, Mentzer SJ, et al. Prevention, early detection and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004;128:138\u2013146.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"915_CR5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1067\/mtc.2001.116560","volume":"122","author":"V.W. Rusch","year":"2001","unstructured":"Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122:788\u2013795.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"915_CR6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","volume":"117","author":"D.J. Sugarbaker","year":"1999","unstructured":"Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, et al. Resection margins, extrapleural nodal status and cell type determine postoperative longterm survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54\u201363.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"915_CR7","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","volume":"27","author":"L.M. Krug","year":"2009","unstructured":"Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:3007\u20133013.","journal-title":"J Clin Oncol"},{"key":"915_CR8","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/JTO.0b013e3181ae26ae","volume":"10","author":"T. Treasure","year":"2009","unstructured":"Treasure T, Waller D, Tan C, Entwisle J, O\u2019Brien M, O\u2019Byrne K, et al. The Mesothelioma and Radical Surgery randomized controlled trial: the MARS feasibility study. J Thorac Oncol 2009;10:1254\u20131258.","journal-title":"J Thorac Oncol"},{"key":"915_CR9","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","volume":"18","author":"W. Weder","year":"2007","unstructured":"Weder W, Stahel RA, Bernhard J, Bodis S, Vogt P, Ballabeni P, et al. Multicenter trial of neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007;18:1196\u20131202.","journal-title":"Ann Oncol"},{"key":"915_CR10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","volume":"108","author":"V.W. Rusch","year":"1995","unstructured":"Rusch VW. A proposed new international TNM staging for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Chest 1995;108:1122\u2013118.","journal-title":"Chest"},{"key":"915_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","volume":"53","author":"E.L. Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"915_CR12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1378\/chest.108.3.754","volume":"108","author":"C. Boutin","year":"1995","unstructured":"Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. Chest 1995;108:754\u2013758.","journal-title":"Chest"},{"key":"915_CR13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thx.31.1.15","volume":"31","author":"E.G. Butchart","year":"1976","unstructured":"Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax 1976;31:15\u201324.","journal-title":"Thorax"},{"key":"915_CR14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0022-5223(19)38932-9","volume":"84","author":"P.M. McCormack","year":"1982","unstructured":"McCormack PM, Nagasaki F, Hilaris BS, Martini N. Surgical treatment of pleural mesothelioma. J Thorac Cardiovasc Surg 1982;84:834\u2013842.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"915_CR15","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0360-3016(03)00287-6","volume":"56","author":"S. Yajnik","year":"2003","unstructured":"Yajnik S, Rosenzweig KE, Mychalczak B, Krug L, Flores R, Hong L, et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. J Radiat Oncol Biol Phys 2003;56:1319\u20131326.","journal-title":"J Radiat Oncol Biol Phys"},{"key":"915_CR16","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.athoracsur.2007.04.076","volume":"84","author":"D.C. Rice","year":"2007","unstructured":"Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007;84:1685\u20131692.","journal-title":"Ann Thorac Surg"},{"key":"915_CR17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","volume":"27","author":"M. Perrot De","year":"2009","unstructured":"De Perrot M, Feld R, Cho BC, Bezjak A, Anraku M, Burkes R, et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant highdose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:1413\u20131418.","journal-title":"J Clin Oncol"},{"key":"915_CR18","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","volume":"27","author":"L.M. Krug","year":"2009","unstructured":"Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:3007\u20133013.","journal-title":"J Clin Oncol"},{"key":"915_CR19","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1183\/09031936.00039510","volume":"36","author":"P.E. Schil Van","year":"2010","unstructured":"Van Schil PE, Baas P, Gaafar R, Maat AP, Van de Pol M, Hasan B, et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J 2010;36:1362\u20131369.","journal-title":"Eur Respir J"},{"key":"915_CR20","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"N.J. Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636\u20132644.","journal-title":"J Clin Oncol"},{"key":"915_CR21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.lungcan.2004.11.003","volume":"48","author":"D.E. Maziak","year":"2005","unstructured":"Maziak DE, Gagliardi A, Haynes AE, Mackay JA, Evans WK. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer 2005;48:157\u2013169.","journal-title":"Lung Cancer"},{"key":"915_CR22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jtcvs.2009.02.046","volume":"138","author":"T.R. Tilleman","year":"2009","unstructured":"Tilleman TR, Richards WG, Zellos L, Johnson BE, Jaklitsch MT, Mueller J, et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg 2009;138:405\u2013411.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"915_CR23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6602307","volume":"92","author":"J.T. Hodgson","year":"2005","unstructured":"Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005;92:587\u2013593.","journal-title":"Br J Cancer"},{"key":"915_CR24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.bjc.6600505","volume":"87","author":"A.K. Nowak","year":"2002","unstructured":"Nowak AK, Byrne MJ, Williamson R, Ryan G, Segal A, Fielding D, et al. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma. Br J Cancer 2002;87:491\u2013496.","journal-title":"Br J Cancer"},{"issue":"suppl1","key":"915_CR25","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.lungcan.2005.03.007","volume":"49","author":"R.M. Flores","year":"2005","unstructured":"Flores RM. The role of PET in the surgical management of malignant pleural mesothelioma. Lung Cancer 2005;49(suppl 1):S27\u2013S32.","journal-title":"Lung Cancer"},{"key":"915_CR26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","volume":"12","author":"T. Treasure","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwisle J, et al. Extrapleural pneumonectomy versus no extrapleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011;12:763\u2013772.","journal-title":"Lancet Oncol"},{"key":"915_CR27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","volume":"65","author":"A.M. Allen","year":"2006","unstructured":"Allen AM, Czerminska M, Janne P, Sugarbaker DJ, Bueno R, Harris JR, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006;65:640\u2013645.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"915_CR28","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1097\/JTO.0b013e3181ed0489","volume":"5","author":"C. Cao","year":"2010","unstructured":"Cao C, Yan TD, Bannon PG, McCaughan BC. A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol 2010;5:1692\u20131703.","journal-title":"J Thorac Oncol"},{"key":"915_CR29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","volume":"35","author":"A. Scherpereel","year":"2010","unstructured":"Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010;35:479\u2013479.","journal-title":"Eur Respir J"},{"key":"915_CR30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2009.08.019","volume":"71","author":"S. Bolukbas","year":"2011","unstructured":"Bolukbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J. Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin\/pemetrexed and radiotherapy. Lung Cancer 2011;71:75\u201381.","journal-title":"Lung Cancer"}],"container-title":["General Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-011-0915-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11748-011-0915-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-011-0915-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T18:06:41Z","timestamp":1593886001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11748-011-0915-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,28]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["915"],"URL":"https:\/\/doi.org\/10.1007\/s11748-011-0915-9","relation":{},"ISSN":["1863-6705","1863-6713"],"issn-type":[{"value":"1863-6705","type":"print"},{"value":"1863-6713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,28]]}}}